Background COVID‐19 illness is highly variable, ranging from infection with no symptoms
through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough …

Anosmia, the loss of the sense of smell, is one of the main neurological manifestations of
COVID-19. Although the SARS-CoV-2 virus targets the nasal olfactory epithelium, current …

The sense of smell is interrelated with psychosocial functioning. Olfactory disorders often
decrease quality of life but treatment options for people with olfactory loss are limited …

Background: Olfactory training is the only evidence-based treatment for post-viral olfactory
dysfunction. Smell disorders after SARS-CoV-2 infection have been attributed to …

Background The aim of this study was to estimate the prevalence of self‐reported
chemosensory dysfunction in a study cohort of subjects who developed a mild‐to‐moderate …

SARS-CoV-2 infects less than 1% of cells in the human body, yet it can cause severe
damage in a variety of organs. Thus, deciphering the non-cell-autonomous effects of SARS …

Background: Sudden smell loss is a specific early symptom of COVID-19, which, prior to the
emergence of Omicron, had estimated prevalence of~ 40% to 75%. Chemosensory …

The human sense of smell is still much underappreciated, despite its importance for vital
functions such as warning and protection from environmental hazards, eating behavior and …

Purpose The aim of the present study was to estimate the 1 year prevalence and recovery
rate of self-reported chemosensory dysfunction in a series of subjects with previous mild-to …

This study prospectively assessed the 6-month prevalence of self-reported and
psychophysically measured olfactory dysfunction in subjects with mild-to-moderate COVID …